Sotera Health (NASDAQ:SHC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Sotera Health (NASDAQ:SHC) from a buy rating to a strong-buy rating in a research report sent to investors on Sunday,Wall Street Zen reports.

A number of other research analysts have also recently weighed in on SHC. Piper Sandler restated an “overweight” rating and set a $25.00 target price on shares of Sotera Health in a research note on Tuesday, September 8th. Barclays increased their price target on Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. Weiss Ratings lowered Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday. JPMorgan Chase & Co. reissued an “underweight” rating and set a $17.00 price target on shares of Sotera Health in a report on Wednesday, October 14th. Finally, Citigroup raised their price target on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.38.

Sotera Health Trading Up 0.5%

NASDAQ SHC opened at $18.49 on Friday. Sotera Health has a 12 month low of $13.09 and a 12 month high of $19.85. The stock has a market cap of $5.28 billion, a price-to-earnings ratio of 32.44 and a beta of 1.85. The company’s 50 day moving average is $18.54 and its two-hundred day moving average is $17.05.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The firm had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Sell-side analysts forecast that Sotera Health will post 0.87 EPS for the current year.

Insider Buying and Selling at Sotera Health

In related news, Chairman Michael B. Jr. Petras sold 850,000 shares of Sotera Health stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman directly owned 3,969,393 shares of the company’s stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael P. Rutz sold 150,000 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 1,294,515 shares of company stock worth $23,999,528. Insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of SHC. Darsana Capital Partners LP raised its holdings in shares of Sotera Health by 3.8% in the second quarter. Darsana Capital Partners LP now owns 27,000,000 shares of the company’s stock worth $479,250,000 after buying an additional 1,000,000 shares during the period. BlackRock Inc. bought a new stake in shares of Sotera Health during the 2nd quarter worth approximately $428,635,000. Sculptor Capital LP bought a new stake in shares of Sotera Health during the 2nd quarter worth approximately $426,000,000. Jupiter Topco LLC purchased a new position in Sotera Health during the 2nd quarter valued at $149,137,000. Finally, Janus Henderson Group PLC boosted its holdings in Sotera Health by 35.3% during the 1st quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock valued at $131,413,000 after acquiring an additional 2,390,132 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.